throbber
50453891 4
`
`09/08/201 7
`
`PATENT ASSIGNMENT COVER SHEET
`
`Electronic Version v1.1
`Stylesheet Version v1.2
`
`EPAS ID: PAT4585621
`
`
`SUBMISSION TYPE:
`NEW ASSIGNMENT
`
`
`NATURE OF CONVEYANCE:
`ASSIGNMENT
`
`CONVEYING PARTY DATA
`
`ALLERGAN, INC.
`
`RECEIVING PARTY DATA
`
`09/08/2017
`
`m SAINT REGIS MOHAWK TRIBE
`Street Address:
`412 STATE ROUTE 37
`
`
`City:
`AKWESASNE
`
`NEW YORK
`State/Country:
`13655
`Postal Code:
`
`
`PROPERTY NUMBERS Total: 6
`
`
`Property Type
`Number
`
`8633162
`Patent Number:
`
`
`
`
`
`
`Patent Number: 8648048
`
`
`
`Patent Number:
`
`8685930
`
`9248191
`Patent Number:
`
`
`CORRESPONDENCE DATA
`
`(714)246—4249
`Fax Number:
`Correspondence will be sent to the e-mail address first; if that is unsuccessful, it will be sent
`using a fax number, if provided; if that is unsuccessful, it will be sent Via US Mail.
`Phone:
`714-246-4500
`
`Email:
`Correspondent Name:
`Address Line 1:
`Address Line 4:
`
`patentsiip@allergan.com
`ALLERGAN, INC.
`2525 DUPONT DRIVE, T2—7H
`IRVINE, CALIFORNIA 92612—1599
`
`ATTORNEY DOCKET NUMBER:
`
`17618
`
`
`NAME OF SUBMITTER:
`LAURA L. WINE
`
`
`SIGNATURE:
`/Laura L. Wine/
`
`DATE SIGNED:
`
`09/08/2017
`
`Total Attachments: 6
`
`504538914
`
`PATENT
`REEL: 043532 FRAME: 0422
`
`SRMT 2103 - Pg. 1
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01 129
`
`SRMT 2103 - Pg. 1
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01129
`
`

`

`source=Short form-Patent Assignment - Signed#page1.tif
`source=Short form-Patent Assignment - Signed#page2.tif
`source=Short form-Patent Assignment - Signed#page3.tif
`source=Short form-Patent Assignment - Signed#page4.tif
`source=Short form-Patent Assignment - Signed#pag95.tif
`
`source=Short form—Patent Assignment — Signed#page6.tif
`
`PATENT
`REEL: 043532 FRAME: 0423
`
`SRMT 2103 - Pg. 2
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01 129
`
`SRMT 2103 - Pg. 2
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01129
`
`

`

`EXECIZITIQ " IEKSIGN
`
`SHORT KERN! §ATEP€T A$SIGF€MENT
`
`This Pawn: Assignmsm {this “Assignment? i5 mafia a3 {If Swimwear E‘s, 269i?
`{mach time, the: "Efi‘ect‘aw Data”), by am bahwsn faiiaza‘gma, has; a fleiawzaas coagmaasama
`{“Assigxmrfi and Sam Ragis Mahawk ‘Txibaa‘ a feaieraiiyamsatagniwd mvemign Native:
`Ameaiaaaata Tram {“Assiguw‘fia
`
`WHEREAS, Assagmr was 1312 patients emai gamma apg‘aiimticias SSE farm in
`Mackinaw! A {the ‘“§’aa€aaaat§“ja;
`
`WHEREAS) Assigmar dassa‘a‘es m asgigaa, mansfksay 8:3;va and aisli‘aaea‘ as
`Assignee; and Ass‘agfiefi Wis-has m acqaaa’aaza fauna Assigmn aii a)?” iés aigixé’, aifle and Waves; in, {a}
`and under aha Patemss; and
`
`WHEREASa pursuant ts: ami £2903 the terms, {3in mamas» mad mafiiticns oi; the
`Patent Assigaamcm figmemeaaa aimed as If Sagatfimber 3, 3:31? was: “Lang Ema Agreamasnfl!
`Isa}! mi heawaaen Assigmr 2am Assigaaem s‘assigaaoa desia'es to wnfirm amai yeafeqt its assaignmena,
`33:22am; mma‘fiygaaw and (flailiwry to Amigame 3f gel} azaf its right, Eitk: amai imam-:3: In, an anti
`maxim file: Famms and 31a,
`is} ami waiter the: ixwismimas rammswmd iharehy, ami Asségm‘c is
`dwimus m‘f wafimia‘ag and yerfmzamg ti’m 3mm.
`
`NGW5 Ti-IEREFQRE, for gmai and vaiuzahie maasidfimtiam, aha messigt am
`sufficienaty a?“ wh‘ach are: Eaamaby‘ aeka‘mwiedgmi, Em: mamas Imam immding Eat: he: iegafiy
`hammi hemiay Engage as fafiaws:
`
`Ia Amaggagawm As: {if the Effmtiva: Date, Assi‘jamr harem wave-33, irazasfaaa‘s, assigns
`aaaai defines-s m Assigaam and Aggigaase Eaaamby gamma the from Aasfigma, an sf
`Assagmaka right aétie am magma: as: m and under aha Paaems, aogazahgr with my
`missuzsa rascxamnmmm, davisiamaaa aezatimamiom‘ somtia‘auaatiamsaéaawpm, <2:m:a:*a3iamasw axed
`{WEE-W ads a?" smash Assigned i’aimts aaIratady ga‘gnaeai and whack may he: gi‘amteai {karma
`T313 assaigfimem attaratcmpimcci bargain i3 mam: ta be: an ahsaime assaaiglm‘amt am? mt hy
`may of 329mb}-
`
`g»;
`
`figfiil akasurances As may as nacaassaarya Assigmr shall exacaatfia afikaaaawiséga: and
`(waver such ether iaasatmmm‘as, dmaamma‘g mad ggmemems and Shani: do sash cake:
`flag as may be magsagmahiy nexessaay garage: or advisahiaa ta) earry 0m: fig cabiigaaioaas
`anaifir this. Agageaaaem' anti as may he a‘easmaab‘w mwasa‘mfia‘ pmpsr 9r adviszfiaia: {a more
`mmnIattazIy afiarctime.
`floa‘aa‘aamaamta
`remaai perfect
`tar canfiam {I‘m :3mmctionas
`maifimyfiamé haxfisya
`
`3 Rama‘datim. The Awigmaa“ harem aaat‘hmizaas the magma: of Panama‘s and 'i‘maammrks
`iaa figs {Suited Siam Fatwa and demma’k {affise {a} award Amigaaee as the assigns
`and name: of that Assigmxl Paaaaaats anai to aieiivaa‘ to Asaaégraca‘z, 33¢ {a MSa‘gfiaae‘s
`ataaramegaas‘ agents, gaaaraessea‘s aaa‘ aassigazaaa, an (afiicaai documaaaats 2am: cmmmmieatiatsais as
`may be: warmmai by 313:; Aaqs‘agmzaang aaachadéaag but not limilmi t0 igm’mg any and all
`Lama‘s E’amfis Of @123: {faitéé Saws 9:: invenmnsa céaaa‘amd 5:32 the Famam
`
`
`4a SFJngfigjgggfiy '
`:g3f3fgggagiggjflmggigi. Asatigaafie a‘egaamseaxm {hat it 313a: my! anti wiii
`mt waive its safefi'era‘igzn immunity car
`{1‘15 smemign immunity {if any Cvmngasany,
`caugxamiim caaaasaprisa‘:
`au‘aiaaaa‘aay fia‘visima‘
`fiaabaiivisian, ham-5&1 9r athar agmmyv
`ixastmneaataiiay as: {3th gmmamem wmmneafi (a? ASsignse {mafia {3f 33% {wagging» a
`
`'v't/"a{73% REEI.
`
`(,
`
`M11
`
`SRMT 2103 - Pg. 3
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01 129
`
`SRMT 2103 - Pg. 3
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01129
`
`

`

`ix; was}: cage, in mimim in my Enter panes
`imiudifig Asségme, a ""Frihal 3.3mm”),
`mviaw fix“ any other pmmeding in the, {Emmi States Patent £2: '"fmdemark Officfi a): any
`afiminismm‘e pmcmxfiing that may he flied far ‘Ehi: panama m“ invsfiaiatmg 9r rmdming
`uneufmmahie any Agsignfisd E’aaenm. 250; garpuges 9f thia Asmignmm: Agrgaemem. m3
`pmvésimz {if this Assiigmmm Agrezsmgm simuki 32:2: mtemmicé is: mnsiimta & waiver a?“
`ASSigszeés’s mt may ether Tribai i-‘axrijfifi sawmigm immunity as Ea any imr pémas mvicw
`m sémifar pmaeaufizzgés.
`
`i
`
`figfixggfimfizgfi A'ssigmr ami Assigme gash ackmwiadgfi and agrm this: the
`i‘cgiresesxmfims, waré‘émtiea mwmmis, ahligatiesxiz and mixer terms mistaineii in 3316:
`{mag Fem Agremnm! ghaii mi 33:: satpfimeziad hembys but $113.3} ramain in 52.312 fame
`mid cfi‘ect m fihfi‘: Suki Miami gresvifimi therein, "$0 the extem m: as}! prawiaim at“ this
`Assigfiment fig incmsmcm m" canfiicts with the Long Farm Agmemem, the §zmvi§ims
`affine Long Form Agmemem shaii unmet 'Z‘he partigs may enema M3 Agsigm‘nem
`in muhépia catamarans, my me (pf wkiafiz maxi 530: (imam the figmmm csf mere: than
`some party, but aii swath mummpam taken mgmfiax 33m}! wastimir: am: and the same:
`inmumam Any mumerpam may be: axecuteii hy fagsimiig gr H3? sigmaime and such
`é‘aca‘imiic (2: FE)? sigmtm 9213:: be damefi am mgfmi. Time {ms and mmfitims {in}?
`this Asaignmem shaii fire Wading; 133mm 12:: pam‘gs {mete am: their mapsefim same-35013
`ami RSSigfiS, This Assigmmn: shali be gowmed E3}! and camsmsed in awofiiaams with
`the: iaw 9f the Stage 0.? Naw Yam without givifig effect to the pziucipies <3?“ sonfiicig
`Sf an timmef‘,
`
`{Signm‘wm $331853“ 0:: 3%: F5:21.59 24mg 33;:ng x}
`
`m;
`
`
`ata}.‘W.
`"i
`
`,WWW/ma
`
`mime.I
`
`
`
`am?“
`
` N
`x“
`.
`REELfiéfi353i» AME: 0425
`
`‘
`
`SRMT 2103 - Pg. 4
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01 129
`
`SRMT 2103 - Pg. 4
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01129
`
`

`

`LN WERE-SS TEiEREGF, Assigmr and A5sigaxe§ have gamad {Emir mspactivs £3313};
`authorized ei‘ficm to enema ihis A‘sxigmnem 333 ai‘ the Effective Date.
`
`33313333 Rggis Mahawk Tribe:
`
`Miergam Sam 3
`
` 133*MW
`
`3
`
`Names: Eria Thampxm
`
`Name: A Rfibfifi DFBai'iey
`
`Title: Tyibai Chief
`
`“Mia:
`
`Frzfisidezfl
`
`
`
`3833333333: Sawfly Cm}:
`
`T3316: Tribai Chief
`
`Name: Michaei (333333332333
`
`“rifle: Tribal Chief
`
`33‘3333;3333’5 3333333 333 3333‘:3: 3331333333 33333333333“ (itsw‘mfis3‘23 gig:{?§?5??€‘§3!
`i3?
`
`
`
`REEL.“343332
`AME: 0426
`
`SRMT 2103 - Pg. 5
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01 129
`
`SRMT 2103 - Pg. 5
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01129
`
`

`

`.émigmm .33 n~ T3233 Paiggga:
`
`
`
`Ahamimafi
`23333213122302.3222:
`
`
`
`
`
`
`
`
`................................................................................................................
`.
`...._._._..
`
`‘”
`' S-mmssfimmmrg”3
`3
`
`5,354,?.39
`17~RE8V~1994
`
`......i
`5 §33 33:10?
`3233-33333433538
`3
`
`
` {BnNfiv-EGQE
`
`63‘3???4533“
`2;:W33“233257332323
`
`
`
`2:21:25“? 272
`
`
`:64’351’36
`32.32323322223233333
`2.33.223223339” 3
`
`
`
`mnmgnm
`23—33222-2222242
`2332;327:3228
`
`iénAug-Em 3
`
`
`
`3 {34S{34%
`
`
`\,§§S.§3G
`23,3252 8323
`(32222122323232
`3
`33233922424233
`
`
`
`’33 «Max:333 3 4”“4..-
`23.2.22: 391S2«¥e3>«2§36314i22233?3 3
`
`
`..-..-
`3 ””33””
`33
`3
`3229222325
`3374321155.‘3333
`3
`
`.
`_
`...3...
`________________
`
`_finnAug.333 13
`3
`1319618133?
`,
`
`:
`‘7 Augn’33333
`
`....53......
`
`
`”E‘ssnii'ig”
`
`
` 233,302 2 2:223
`
`
`_ 3333422432225
`_
`..
`ahandoaad
`
`323233323” 33
`
`Lamaze vawmml
`3.322,pnzg3m
`
`
`
`2323223225’:
`21LAagn23.304
`Abgimiam‘d
`
`
`
`
`
`
`323.293.323.054
`232332222332222
`iSnNm‘ngfiiMi
`
`21.3439,
`‘
`13.0033.
`
`
`
`
`
`33?».3‘3wé333)”
`Abamiutmi
`n
`3
`31f§§3§€35
`
`........--.....-.-...-?--..W---...-...--£................................ ...........“..............---..---.
`...................
`
`
`
`
` .W.--W.fi-
`3
`234222—3949
`.
`32322222232233.3222
`.
`-
`3E5§€3£32
`
`
`
` 23.322233
`7 153 3335“”
`39259238333
`3&ch—
`
`?833232.355”
`23242233333232;
`22-34394333” '
`
`
`
`“2333.33.33”
`222223252233
`
`
`
`
`
`
`
` 33 322222222313
`22023
`W33..
`
`
`
`.
`384312—2332 i 2";
`
`m..._.‘.‘umum.5..ww_w-.....WM..........3
` “3' $335,479
`
`3312134233335
`232222.523:
`”3 33' 3 8 E .,
`
`
`
`
`
`
`
`
`”3%”222355
`
`__3MLRHZ
`33/857.33'
`3
`3k
`
`‘
`‘
`‘
`‘
`.nifiexz‘émmz‘ .33 3‘23 Shaw Farm P33553233: 23.325333392223322“3332;362:333;.23:
`
`
`23°
`5
`L ’
`
`.-‘ Rafi ”mi {.33
`3
`3 f3».
`3
`‘
`z
`
`.-
`
`Agm
`:”U43552 FRAME: 0427
`
`RE
`
`SRMT 2103 - Pg. 6
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01 129
`
`SRMT 2103 - Pg. 6
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01129
`
`

`

` E
`
`
`
`“““
`
`“mm“mum.“
`“.344“
`
`
`
`E11131; 13.1113
`1
`3131123 3 63113333533135
`,
`"3321::‘
`.............
`
`
`3313331113
`8575.133"
`1.119411,6$3
`15.31113~21ij
`
`
`
`
`
`131333333“: 331332313
`
`1 3Ma:2015
`
`
`
`335336:
`111135343
`j “1713131333
`
`
`
`
`11331423 E
`33313334331
`133633333"
`
`
`7".§§?:T9.1..1...1W1Ff: 3323
`E3613136311117
`
`
`111391133 1333132313
`
`
`
`
`13635,731 23133.231
`-
`
`
`
`E33133}
`US
`;
`“313363313‘”1 2133333333
`
`
`
`
`m7"
`‘391111861
`_13.2361333wa 231332303
`
`
`
`m1E338631
`‘
`
`
`
`
`1393:9,???)
`93981131de
`
`
`
`
`13!95£§,8<19
`3331;333:1311
`
`Abanéflnfid
`
`
`
`
`11.131135111116311
`
` ‘
`
`
`
`
`
`331131113
`131333333
`241632313
`'
`13:35;5335
`:1.312133633
`3332136ng
`
`
`
`
` - -_...
`«4.4.4.144
`
`
`
`1139512111 vaésiaz331
`1
`.
`.
`3315333133W“"
`
`3:1613333““1W13331,13:
`
`
`
`Afimfiomd
`
`
`33332131011561
`
`
`Pending
`391313-1311
`
`..~
`. M33AMWW
`
`331313213:239
`251111291351
`iE19336 vai§m§m§
`
`WWWMWNWM;
`}
`
`--
`’
`61153291196
`2’3Qciuififié
`flawed E’mvigimmi
`1
`““"m'"
`"m“!
`
`
`
`
`E63933:
`“1333163013 .
`_
`femiing
`
`:133663311
`“13133111101363
`
`
`
`
` " 51'169196 11393611 11311323613331
`
`1‘61"?”1 95"
`
` W .............‘L“W
`E'E3.6132313 1
`
`
`
`RE “”64353fi5RAME: 0428
`
`SRMT 2103 - Pg. 7
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01 129
`
`SRMT 2103 - Pg. 7
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01129
`
`

`

`
`...........
`ril
`1
`1
`=
`\
`
`E33122: 3mg '
`gERfiM. N9.
`FSLEN'G 3&3’3
`$TATE;S s" 1:.Gmfi‘N’E‘E
`E1I
`
`.......,..
`“mm...“mw
`.
`.»
`
`fififfififiwfir 4 1212523323009
`E
`lapsed vaiskmai
`
`
`
`
`WW WW WWWWWWWWWWWWWWWWWWWWWWWWWWWW 25WWLagsggMWWW
`Si!347,851
`
`
`
`132‘ 123,754
`25Via?29H
`Ahanmnefi
`3225223155: Z’LEEE2314
`
`
`
`Fmfiing
`
`
`Abandened
`
`
`2;;Eiiggj‘"“’“"
`
`
`
`.
`
`. ESMm;3814
`
`
`
`
`:23Feb.2325
`
`Abanéemsd
`Akanéégeg
`Pegging
`
`
`
`
`
`REEL: 0435
`
`FRA E: 0429
`
`RECORDED: 09/08/2017
`
`SRMT 2103 - Pg. 8
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01 129
`
`SRMT 2103 - Pg. 8
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01129
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket